A new population-based study by Canadian researchers shows that women in the second trimester of pregnancy run a substantial risk of serious motor vehicle crash. The findings were published in the May 12 edition of The Canadian Medical Association Journal.
A new population-based study by Canadian researchers shows that women in the second trimester of pregnancy run a substantial risk of serious motor vehicle crash. The findings were published in the May 12 edition of The Canadian Medical Association Journal.
More than 500,000 women aged 18 and older who gave birth in Ontario between April 1, 2006 and March 31, 2011 were included in the research. The primary outcome of the population-based self-matched longitudinal cohort analysis was a motor vehicle crash that resulted in a visit to the emergency department. The investigators compared the risk of a serious motor vehicle crash during the second trimester to the women’s baseline risk before pregnancy.
During the 3-year baseline period, the women were drivers in 6,922 motor vehicle crashes, compared with 757 during the second trimester of pregnancy alone, an increase from an average of 177 per month to 252 per month. That 42% relative increase (95% confidence interval 32%-53%; P<0.001) held true in diverse populations, varied obstetrical cases, and in crashes with differing characteristics.
The researchers found that the increased risk was greatest in the early second trimester and was compensated for by the third trimester. It was not observed when the women were passengers or pedestrians in crashes. The findings, the authors concluded, “underscore the importance of prevention and suggest that prenatal care guidelines for pregnant women should include safe driving.”
To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary Ob/Gyn Special Delivery.
Fasting glucose at GDM diagnosis may predict postpartum glucose abnormalities
February 6th 2025A recent study suggests that elevated fasting glucose levels at the time of gestational diabetes diagnosis could be an early indicator of postpartum glucose intolerance, emphasizing the need for close monitoring after delivery.
Read More
Ulipristal plus misoprostol shows promise for medication abortion
February 5th 2025A recent study found that ulipristal acetate followed by misoprostol is a safe, effective, and acceptable option for medication abortion, offering a potential alternative in areas with limited access to mifepristone.
Read More
Identification and management of patients at increased risk for breast cancer
February 5th 2025With breast cancer being the most diagnosed invasive cancer in the United States, OB-GYN practitioners play a crucial role in identifying high-risk patients and guiding them through screening, prevention, and risk-reduction strategies.
Read More